Neurology & Neuroscience

Objective: The objective is to prove efficiency of Multitherapy in treatment of Dyslexia and Acquired Dyslexia .

 

Methods: Many years ago, researchers insists on showing Dyslexia with genetic/hereditary cause, which requires continuous treatment. After many years of advocacy on the theme Acquired Dyslexia, Anna Lou Olivier can say that dyslexia can also be acquired by an accident (anoxia /hypoxia, stroke among others), it is now official for years. What little or nothing is disclosed it is that most of the symptoms attributed to the Dyslexia is actually comorbidities that arise not always while Dyslexia, in most cases, comorbidities arises after some time of diagnosis and treatment inadequate, instead of regress, Dyslexia is aggravated by comorbidities that would not exist if the case had correct diagnosis and effective treatment. This is where the multitherapy, created by Anna Lou, differs and acts more effectively in that it detects the actual symptoms of the patient and is broadly developing its creativity, memory and enabling a new way of learning.

 

Results: More than 25 years applying Multitherapy in clinic and school, the result is very satisfactory in 80% of cases.

 

Conclusion: The Multitherapy is efficient, fast and innovative in the treatment of Dyslexia, Acquired Dyslexia and other learning disorders Multitherapy, welcome at Therapy of the future by Anna Lou Olivier.

 

Keywords: Dyslexia, Acquired Dyslexia, Learning Disorders, Treatment and Multi-therapy